THE MITOCHONDRIAL DNA transfer RNA
Leu(UUR) A3243G mutation was first described in patients with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) syndrome in 1990 by Goto et al.
1 During the past 10 years, numerous other phenotypes of the A3243G mutation have been reported: chronic progressive external ophthalmoplegia,
2 diabetes mellitus and deafness,
3 cardiomyopathy,
4 painful muscle stiffness,
5 MERRF (myoclonic epilepsy with ragged-red fibers) syndrome,
6 and dystonia.
7 The A3243G mutation is regarded as the most frequent mitochondrial point mutation. In a Finnish population, prevalence was estimated to be greater than 16 in 100 000.
8